DBV Technologies (DBVT) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

DBVT DBV Technologies

Watchlist

4.450
+0.250+5.95%

Close Feb 28 16:00 ET

91.30MMarket Cap-0.84P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
GlobeNewswireFeb 25 16:01 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaFeb 4 07:05 ET
DBV Technologies Reports H2 Liquidity Contract Update: 267K Shares, €107K In Account; 1,682 Buy And 1,800 Sales Transactions Covering 404K Shares Purchased, €296K And 441K Shares Sold, €341K
BenzingaJan 13 16:12 ET
Half-Year Report on the DBV Technologies Liquidity Contract With ODDO BHF
GlobeNewswireJan 13 16:05 ET
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
MT NewswiresJan 13 11:09 ET
DBV Technologies Analyst Ratings
BenzingaJan 10 10:09 ET · Ratings

Comments

Jaguar8

Jan 9 15:27

🔵 Watchlist JANUARY 10,2025, Friday. NFA. Quite long because of Wednesday’s red day and Thursday good news… in progress

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...

110

Trytosaveabit

Jan 8 15:09

News

$DBV Technologies (DBVT.US)$ DBV Technologies Announces 3-Year Results From EPITOPE Phase 3 Open-Label Extension Study; Data Provided Support That Continued Treatment With VIASKIN Peanut Showed Improveemntn Through 36 Months Of Treatment Across All Efficacy Parameters
Benzinga· 1 min ago

Jaguar8

Jan 8 15:05

NEWS

$DBV Technologies (DBVT.US)$
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
Wednesday, 8th January at 4:05 pm
Châtillon, France, January 8th, 2025
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
EPITOPE OLE data demonstrates continued improvement in treatment benefit of VIASKIN® Peanut patch in toddlers 1 – 3 years through 36 months
68.2% of subjects completed the oral food challenge (~12...

Mafiosa818

Dec 12, 2024 11:15

$DBV Technologies (DBVT.US)$ 👀

DBVT DBV Technologies

Trade Overview

Capital Trend

News

Comments

Trending Stocks